Css LLC Chimerix Inc Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $63,350 - $96,599	35,000 Added 39.11%	124,500 $240,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $30,150 - $120,150	22,500 Added 33.58%	89,500 $186,000
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $251,900 - $374,000	55,000 Added 458.33%	67,000 $307,000
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $71,280 - $105,000	12,000 New	12,000 $74,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.